Table 1 Clinicopathological characteristics of LDH patients and control patients with TCS
Patients ID | Samples | Gender | Ages | Pfirrmann | Segment |
|---|---|---|---|---|---|
1 | TCS | Female | 18 | 1 | L4/L5 |
2 | TCS | Male | 18 | 1 | L4/L5 |
3 | TCS | Male | 28 | 1/2 | L3/L4 |
4 | TCS | Female | 36 | 1/2 | L4/L5 |
5 | TCS | Female | 18 | 1 | L1/L2 |
6 | TCS | Female | 18 | 1 | L2/L3 |
7 | TCS | Female | 18 | 1 | L3/L4 |
8 | TCS | Male | 19 | 1 | L2/L3 |
9 | TCS | Male | 19 | 1 | L3/L4 |
10 | LDH | Female | 51 | 4 | L3/L4 |
11 | LDH | Male | 40 | 3 | L4/L5 |
12 | LDH | Male | 22 | 3/4 | L4/L5 |
13 | LDH | Female | 28 | 4 | L4/L5 |
14 | LDH | Male | 62 | 4 | L4/L5 |
15 | LDH | Male | 63 | 4 | L3/L4 |
16 | LDH | Male | 63 | 3 | L3/L4 |
17 | LDH | Female | 67 | 3/4 | L5/S1 |
18 | LDH | Male | 37 | 3 | L3/L4 |
19 | LDH | Male | 64 | 4/5 | L3/L4 |
20 | LDH | Male | 56 | 4/5 | L4/L5 |
21 | LDH | Male | 55 | 4 | L4/L5 |
22 | LDH | Female | 67 | 4 | L4/L5 |
23 | LDH | Female | 47 | 4 | L4/L5 |
24 | LDH | Female | 54 | 4/5 | L2/L3 |
25 | LDH | Female | 54 | 3 | L4/L5 |